Erythropoietin in Heart Failure and Other Cardiovascular Diseases: Hematopoietic and Pleiotropic Effects
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
355-375
Author(s):
Antonis S. Manolis, Stylianos Tzeis, Kostas Triantafyllou, John Michaelidis, Ioannis Pyrros, Nikolaos Sakellaris, Athanasios Kranidis and Helen Melita
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
393-419
Author(s):
Christian Hafner, Albrecht Reichle and Thomas Vogt
Proteomics in Acute Myelogenous Leukaemia (AML): Methodological Strategies and Identification of Protein Targets for Novel Antileukaemic Therapy
Journal:
Current Drug Targets
Volume:
6
Page:
631-646
Author(s):
G. Sjoholt, N. Anensen, L. Wergeland, E. Mc Cormack, O. Bruserud and B. T. Gjertsen
Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
5
Page:
805-824
Author(s):
Erik De Clercq
The Role of DNA-Microarray in Translational Cancer Research
Journal:
Current Pharmacogenomics
Volume:
3
Page:
201-216
Author(s):
Sonke Korfee, Wilfried Eberhardt, Yasuhiro Fujiwara and Kazuto Nishio
Targeting Transcription Factors for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
2873-2887
Author(s):
M. S. Redell and D. J. Tweardy
Inflammation and Cancer: When NF-κB Amalgamates the Perilous Partnership
Journal:
Current Cancer Drug Targets
Volume:
5
Page:
325-344
Author(s):
Marina A. Dobrovolskaia and Serguei V. Kozlov
Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
5
Page:
337-343
Author(s):
G. Barbaro
Protein Z and Ischemic Stroke
Journal:
Vascular Disease Prevention (Discontinued)
Volume:
2
Page:
245-250
Author(s):
Y. Sun, F. Wen and H. Y. Yao
Specific Biologic Therapy with Tumor Necrosis Factor Inhibitors in Patients with Inflammatory Myopathy
Journal:
Current Rheumatology Reviews
Volume:
1
Page:
157-165
Author(s):
Moises Labrador-Horrillo and Miquel V. Tarres